{"id":10963,"date":"2024-02-06T09:33:18","date_gmt":"2024-02-06T01:33:18","guid":{"rendered":"https:\/\/mbi-bio.com\/news\/20240206\/"},"modified":"2024-02-06T09:33:18","modified_gmt":"2024-02-06T01:33:18","slug":"20240206","status":"publish","type":"news","link":"https:\/\/mbi-bio.com\/es\/news\/20240206\/","title":{"rendered":"MBI Secures Exclusive Authorization for Advanced Aesthetic Medical Materials Production from JBP Group"},"content":{"rendered":"<p>MBI has announced a strategic alliance with RE Biotech, a subsidiary of Japan Bio Products Co., Ltd. (JBP), marking a significant step in deepening its presence in the international beauty market. JBP, a global leader in placenta extract, grants MBI the authorization to co-develop and manufacture advanced cosmetic medical materials. This collaboration aims to tap into global opportunities in the beauty industry.<\/p>\n<p>&nbsp;<\/p>\n<p>JBP, specializing in placenta-based pharmaceuticals since 1956, holds an 80% global market share in placenta injections, making it a renowned expert in the field. RE Biotech, an internal startup within JBP, has developed collagen and stem cell-derived products with strong government support.<\/p>\n<p>&nbsp;<\/p>\n<p>The three-year effort to establish this strategic alliance with RE Biotech positions MBI as a leader in the collaboration. The partnership has received high recognition from the JBP Group, injecting new vitality into the international biotechnology beauty industry.<\/p>\n<p>&nbsp;<\/p>\n<p>President Cindy Chen emphasized that this alliance underscores MBI&#8217;s excellent product quality and outstanding position in medical material research and development. With one party providing raw materials and the other handling manufacturing, the collaboration establishes a cooperative ecosystem for cosmetic medical materials.<\/p>\n<p>&nbsp;<\/p>\n<p><img fetchpriority=\"high\" decoding=\"async\" class=\"alignnone size-full wp-image-8889\" src=\"https:\/\/mbi-bio.com\/wp-content\/uploads\/JPB-MBI_02.jpg\" alt=\"\" width=\"728\" height=\"632\" \/><\/p>\n","protected":false},"featured_media":10965,"template":"","news-category":[142],"class_list":["post-10963","news","type-news","status-publish","has-post-thumbnail","hentry","news-category-official-news-es"],"acf":[],"_links":{"self":[{"href":"https:\/\/mbi-bio.com\/es\/wp-json\/wp\/v2\/news\/10963","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mbi-bio.com\/es\/wp-json\/wp\/v2\/news"}],"about":[{"href":"https:\/\/mbi-bio.com\/es\/wp-json\/wp\/v2\/types\/news"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/mbi-bio.com\/es\/wp-json\/wp\/v2\/media\/10965"}],"wp:attachment":[{"href":"https:\/\/mbi-bio.com\/es\/wp-json\/wp\/v2\/media?parent=10963"}],"wp:term":[{"taxonomy":"news-category","embeddable":true,"href":"https:\/\/mbi-bio.com\/es\/wp-json\/wp\/v2\/news-category?post=10963"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}